Dr. Jolles founded Special Gynecology and Oncology in 1994. The practice is centered around Dr. Jolles’ desire and ability to help each patient fully understand her medical condition, treatment options, recovery process, and after-care. Dr. Jolles encourages questions and does whatever it takes to make sure that you have complete knowledge of your problem and your concerns and their resolution. Dr. Jolles’ quick wit and compassion for each patient make it easy to communicate with him.
Dr. Jolles graduated from Yale University School of Medicine in 1976 and served a residency in Gynecology at the University of California San Diego. He then studied gynecologic cancer treatment at the M. D. Anderson Cancer Center which lead to certification by the American Board in both gynecology and oncology.
In 1982 Dr. Jolles accepted a faculty appointment as Director of Gynecologic Oncology at the University of Utah Medical Center and served in that position for 12 ½ years. During that time he served a term as President of the Utah Division of the American Cancer Society and as President of the Western Association of Gynecologic Oncologists. He has been recognized as a Fellow of the American College of Surgeons and a Member of the Society of Gynecologic Oncologists and has completed and published research in women’s cancers. He has taught techniques in cancer surgery both here in Utah and abroad and served seven years as an examiner for the American Board of Obstetrics and Gynecology.
In 1994 Dr. Jolles left the University of Utah and created Special Gynecology and Oncology, a practice dedicated to the treatment of women’s cancers and challenging problems in surgical gynecology. In 2010 he moved the practice to its current location in Riverton, Utah to serve an expanding patient volume.
In early 2007 Dr. Jolles began intensive training in the most modern treatment modality for women with gynecologic cancers: Robotic Surgery. He has the greatest experience in Utah comprising well over 300 cases and has changed the management of endometrial and other cancers in our area. This exemplifies his continuing comittment to remain on the forefront of cancer treatment using minimally invasive approaches.